ASHI Insights
Mar. 24, 2015

ASHI 41st Annual Meeting Call for Abstracts

Abstract submissions are now being accepted for the ASHI 41st Annual Meeting taking place Sept. 28-Oct. 2, 2015 in Savannah, Georgia, USA.

Abstracts submitted will be peer reviewed and considered for oral or poster presentation. Accepted abstracts will be posted on ASHI’s website and published in a supplement of Human Immunology, which will be available at the annual meeting. This publication will be provided to annual meeting attendees in their registration bags. ASHI members who do not attend the annual meeting will receive this publication after the annual meeting.

Please note: There will be no opportunity for late-breaking abstracts this year.

Click here to start the submission process:More

Call for Board Nominations

The ASHI Nominations Committee encourages all ASHI members to nominate candidates for the available officer and board positions. If there are candidates you feel would be an asset to the ASHI Board of Directors, please complete and submit this nomination form to ASHI. All nominations must be accompanied by the signatures of at least 10 full or honorary members in good standing. Email endorsements are acceptable.

By March 23, the Nominations Committee will forward its preliminary slate of candidates to the ASHI membership. This will allow members time to submit additional nominations by the May 4 deadline.More

Call for 2015 Award Nominations

The ASHI Nominations Committee encourages all ASHI members to nominate candidates for the available officer and board positions. If there are candidates you feel would be an asset to the ASHI Board of Directors, please complete and submit this nomination form to ASHI. All nominations must be accompanied by the signatures of at least 10 full or honorary members in good standing. Email endorsements are acceptable.

By March 23, the Nominations Committee will forward its preliminary slate of candidates to the ASHI membership. This will allow members time to submit additional nominations by the May 4th deadline.More

Regional Workshops




The ASHI 2015 Regional Workshop registration is now open!

WORKSHOP 1: San Antonio, Texas Click here to register now!

WORKSHOP 2: Philadelphia, Pennsylvania Click here to register now! (insert link below)

Download your personal copy of the registration brochure now.More

HLA typing using next generation sequencing: An overview
Human Immunology
The introduction of PCR based amplification and sequenc- 13 ing of HLA class I and class II genes revealed a level of polymor- 14 phism far beyond the resolution of serologic or cellular based 15 HLA typing. Now, decades later, the HLA community is still strug- 16 gling to deal with this extensive and ever-expanding allelic diver- 17 sity (12,542 HLA alleles as of January, 2015). The patchwork 18 pattern of polymorphism identified by these initial sequencing 19 studies was primarily localized to the exons that encoded the pep- 20 tide binding domains of class I and class II molecules.More

Stem cell transplant in pediatric leukemia not affected by donor type
Cancer Therapy Advisor
High-risk pediatric patients with acute lymphoblastic leukemia (ALL) see no difference in outcomes after hematopoietic stem-cell transplantation (HSCT) based on donor type, according to a recent study published in the Journal of Clinical Oncology.More

FDA ponders how to regulate next generation sequencing
Managed Care
In light of the tremendous implications for overuse, misunderstanding, and abuse of a person’s genetic and disease-risk data, regulators have a lot to think about. The FDA is weighing the appropriate regulatory approach to next-generation sequencing, in which a single test potentially can be employed to identify a person’s millions of genetic variants. Results of such tests could be used to diagnose or predict a person’s risk of developing disease and to help physicians and patients to determine appropriate courses of prevention and treatment.More